skip to main content
Primo Advanced Search
Advanced search    Note: Search terms must be in lower case
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Date range searching is not available for Article, Issue and Archived Website records; nor does it work for Audio records.

Results 1 - 10 of 12  for Everything in this catalogue

results 1 2 next page
Refined by: journal title: Thrombosis research remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration

Comuth, Willemijn J. et al.

Thrombosis research. Issue 164 (2018); pp 32-39 -- Elsevier

Online access

2
Material Type:
Article
Add to My workspace

Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration

Comuth, Willemijn J. et al.

Thrombosis research. Volume 164: (2018, April); pp 32-39 -- Elsevier

Online access

3
Material Type:
Article
Add to My workspace

Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study

Abecassis, Line et al.

Thrombosis research. Issue 158 (2017); pp 126-133 -- Elsevier

Online access

4
Material Type:
Article
Add to My workspace

International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs

Parry, Blair Alden et al.

Thrombosis research. Volume 166: (2018, June); pp 63-70 -- Elsevier

Online access

5
Material Type:
Article
Add to My workspace

International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs

Parry, Blair Alden et al.

Thrombosis research. Issue 166 (2018); pp 63-70 -- Elsevier

Online access

6
Material Type:
Article
Add to My workspace

Is anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks

Bardy, Guillaume et al.

Thrombosis research. Volume 136:Issue 2 (2015, August); pp 396-401 -- Elsevier

Online access

7
Material Type:
Article
Add to My workspace

Is anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks

Bardy, Guillaume et al.

Thrombosis research -- Elsevier -- Volume: 136 2; (pages 396-401) -- 2015

Online access

8
Material Type:
Article
Add to My workspace

Is anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks

Bardy, Guillaume et al.

Thrombosis research. Volume 136:Issue 2 (2015, August); pp 396-401 -- Elsevier

Online access

9
Material Type:
Article
Add to My workspace

Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations

Godier, Anne et al.

Thrombosis research. Volume 136:Issue 4 (2015, October); pp 763-768 -- Elsevier

Online access

10
Material Type:
Article
Add to My workspace

Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations

Godier, Anne et al.

Thrombosis research -- Elsevier -- Volume: 136 4; (pages 763-768) -- 2015

Online access

Results 1 - 10 of 12  for Everything in this catalogue

results 1 2 next page

Refine Search Results

Subject 

  1. Thrombosis--Periodicals  (9)
  2. Thrombosis  (3)
  3. Anticoagulants--Atrial fibrillation--Blood coagulation tests--Dabigatran--Hematologic tests--Thrombin time  (2)
  4. Pulmonary embolism--Deep vein thrombosis--D-dimer--Age-adjustment--Emergency department  (2)
  5. ACC accuracy--bpm beats per minute--CI confidence interval--CLSI Clinical Laboratory Standards Institute--DVT deep venous thrombosis--dx diagnosis--ED emergency department--fXa factor Xa--HR heart rate--N number--ng/ml nanograms per milliliter--NPV negative predictive value--PE pulmonary embolism--PPV positive predictive value--Pts patients--SD standard deviation--Sens. sensitivity--Spec. specificity--VTE venous thromboembolism--% percentage  (1)
  6. DOAC measurement--PT--aPTT--Direct factor Xa inhibitor--Direct thrombin inhibitor--Anti-Xa activity--Ecarin assay--Dilute thrombin time  (1)
  7. Rivaroxaban--HPLC-MSMS--Chromogenic assay--Anticoagulant--Anti-factor Xa  (1)
  8. ACC--bpm--CI--CLSI--DVT--dx--ED--fXa--HR--N--ng/ml--NPV--PE--PPV--Pts--SD--Sens.--Spec.--VTE--%  (1)
  9. APTT--APTT-Cepha--APTT-PSL--ANOVA--CAT--CT--DMSO--DTI--ECA--ETP--EXTEM--HCl--INTEM--FIBTEM--LC-MS/MS--LD-dTT--MCF--MRM--NOAC--PT--PT-INN--PT-Owren--ROTEM--SE--SEE--TF--TQD--UPLC--VKA  (1)
  10. APTT activated partial thromboplastin time--APTT-Cepha APTT using Cephascreen® (Diagnostica Stago) reagent--APTT-PSL APTT using Pathromtin®SL (Siemens Healthcare) reagent--ANOVA analysis of variance--CAT calibrated automated thrombinography--CT clotting time--DMSO dimethyl sulfoxide--DTI direct thrombin inhibitor--ECA ecarin chromogenic assay--ETP endogenous thrombin potential--EXTEM thromboelastometry testing the extrinsic haemostatic system--HCl hydrochloric acid--INTEM thromboelastometry testing the intrinsic haemostatic system--FIBTEM thromboelastometry testing the fibrin part of clot formation--LC-MS/MS liquid chromatography-tandem mass spectrometry--LD-dTT a laboratory developed diluted thrombin time--MCF maximum clot firmness--MRM multiple reaction monitoring--NOAC non-vitamin K antagonist oral anticoagulants--PT prothrombin time--PT-INN PT using Dade® Innovin® (Siemens Healthcare) reagent--PT-Owren PT using Owrens (Medirox) reagent--ROTEM rotational thromboelastometry--SE standard error--SEE standard error of the estimates--TF tissue factor--TQD tandem quadrupole--UPLC ultra-performance liquid chromatography--VKA vitamin K-antagonist  (1)
  11. Anticoagulant--Anti-IIa--Anti-Xa--PT--aPTT--Surgery  (1)
  12. Refine further open sub menu

Creation date 

From To

Searching Remote Databases, Please Wait